Insights Into Multiple Myeloma (MM) 2023
Perspectives on current treatment practices regarding frontline therapy of MM, the evolving role of MRD testing in MM, treatment in later lines of therapy, and attitudes toward recently introduced agents
Faculty Chair
Jonathan Kaufman, MD
Winship Cancer Institute, Atlanta, GA, USA
Faculty Chair
Hans Lee, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty Chair
Gareth Morgan, MD
NYU Langone, New York, NY, USA
Faculty Chair
Saad Usmani, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
Gareth Morgan, MD
NYU Langone, New York, NY, USA
Faculty Chair
Saad Usmani, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Faculty Chair
Ravi Vij, MD
Washington University School of Medicine
Faculty Chair
David Dingli, MD, PhD
Mayo Clinic, Rochester, MN, USA
Faculty Chair
Amrita Krishnan, MD
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Faculty Chair
Melhem Solh, MD
Northside Hospital, Atlanta, GA, USA
Faculty Chair
Brea Lipe, MD
University of Rochester Medical Center, Rochester, NY, USA
Faculty Chair
Josh Richter, MD
The Mount Sinai Hospital, New York, NY, USA
Faculty Chair
Gareth Morgan, MD
NYU Langone, New York, NY, USA
Faculty Chair
Alfred Garfall, MD
Hospital of the University of Pennsylvania, Philadelphia, PA, USA
More Information
- Atlanta, GA
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Dallas, TX
- Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana
More Information
- Virtual series
- Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Virtual series
- Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Philadelphia, PA
- Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the treatment of MM
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies are obtained: bortezomib, carfilzomib, ixazomib, elotuzumab, daratumumab, lenalidomide, pomalidomide, thalidomide, melphalan, cyclophosphamide, bendamustine, panobinostat, selinexor, isatuximab, and venetoclax
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
